An inhibitor of Bcl-2 family proteins induces regression of solid tumoursTilman Oltersdorf, Saul H. Rosenberg, Stanley J. Korsmeyer et al.|Nature|2005Cited by 3.4k
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing plateletsAndrew J. Souers, Steven W. Elmore, Joel D. Leverson et al.|Nature Medicine|2013Cited by 3k
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapyJoel D. Leverson, Andrew J. Souers, Darren C. Phillips et al.|Science Translational Medicine|2015Cited by 541
Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xLMilan Bruncko, Steven W. Elmore, Thorsten Oost et al.|Journal of Medicinal Chemistry|2007Cited by 295
Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 ProteinsCheol‐Min Park, Steven W. Elmore, Milan Bruncko et al.|Journal of Medicinal Chemistry|2008Cited by 293